Go to
JCI Insight
Abstract
Authors
Lorenzo Leggio, W. Kyle Simmons
Figure 1
The emerging translational landscape of GLP-1–targeted therapies in AUD and other SUDs.
Options:
View larger image
(or click on image)
Download as PowerPoint
ALD, alcohol-associated liver disease; AUD, alcohol use disorder; GLP-1RA, GLP-1 receptor agonist; MetALD, metabolic dysfunction–associated alcohol-related liver disease; SUD, substance use disorder.
Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)